NCT03980275 is a clinical trial in Bilateral Vocal Cord Paralysis, sponsored by Weill Medical College of Cornell University.

Who is sponsoring NCT03980275?

NCT03980275 is sponsored by Weill Medical College of Cornell University.

What condition does NCT03980275 study?

NCT03980275 studies Bilateral Vocal Cord Paralysis.

Is NCT03980275 still recruiting?

NCT03980275 is currently recruiting now. Last updated 20 May 2025.

Last reviewed 2025-05-20 · How we verify

NCT03980275

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

Recruiting now Last updated 20 May 2025

What this trial tests

trial in Bilateral Vocal Cord Paralysis in 15 participants. Currently enrolling.

Timeline

10 December 2019

Primary endpoint
31 December 2030

31 December 2030

Quick facts

Lead sponsor	Weill Medical College of Cornell University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	15
Start date	10 December 2019
Primary completion	31 December 2030
Estimated completion	31 December 2030
Sites	1 location across United States

Conditions studied

Bilateral Vocal Cord Paralysis — all drugs for Bilateral Vocal Cord Paralysis →

Sponsor

Weill Medical College of Cornell University

Who can join

Adults 18 to 70, any sex, with Bilateral Vocal Cord Paralysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2 · NA · not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 · NA · not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression · NA · not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3 · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03980275 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 20 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing